CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: O-acyl carbohydrate
Accession: CHEBI:52782
browse the term
Definition: A carbohydrate derivative in which the hydrogen atom of at least one alcoholic hydroxy group of a carbohydrate has been replaced by an acyl substituent.
Synonyms: related_synonym: O-acyl carbohydrates
G
Acly
ATP citrate lyase
increases expression
ISO
rosavin results in increased expression of ACLY mRNA
CTD
PMID:20706672
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
G
Aqp1
aquaporin 1
increases expression
ISO
rosavin results in increased expression of AQP1 mRNA
CTD
PMID:20706672
NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
rosavin results in increased expression of AQP3 mRNA
CTD
PMID:20706672
NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245
G
Ar
androgen receptor
decreases expression
ISO
rosavin results in decreased expression of AR mRNA
CTD
PMID:20706672
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
G
Cygb
cytoglobin
decreases expression
ISO
rosavin results in decreased expression of CYGB mRNA
CTD
PMID:20706672
NCBI chr10:105,618,325...105,628,091
Ensembl chr10:105,618,326...105,628,091
G
Dsg3
desmoglein 3
decreases expression
ISO
rosavin results in decreased expression of DSG3 mRNA
CTD
PMID:20706672
NCBI chr18:15,652,948...15,688,605
Ensembl chr18:15,650,526...15,688,284
G
Egf
epidermal growth factor
decreases expression
ISO
rosavin results in decreased expression of EGF mRNA
CTD
PMID:20706672
NCBI chr 2:68,820,616...68,895,537
G
Esr2
estrogen receptor 2
decreases expression
ISO
rosavin results in decreased expression of ESR2 mRNA
CTD
PMID:20706672
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
G
Fbn1
fibrillin 1
decreases expression
ISO
rosavin results in decreased expression of FBN1 mRNA
CTD
PMID:20706672
NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120
G
Fbn2
fibrillin 2
decreases expression
ISO
rosavin results in decreased expression of FBN2 mRNA
CTD
PMID:20706672
NCBI chr18:53,068,495...53,272,254
Ensembl chr18:53,068,495...53,181,503
G
Fgf1
fibroblast growth factor 1
increases expression
ISO
rosavin results in increased expression of FGF1 mRNA
CTD
PMID:20706672
NCBI chr18:32,273,830...32,359,831
Ensembl chr18:32,273,770...32,359,824
G
Has1
hyaluronan synthase 1
decreases expression
ISO
rosavin results in decreased expression of HAS1 mRNA
CTD
PMID:20706672
NCBI chr 1:59,720,612...59,732,409
Ensembl chr 1:59,720,612...59,732,409
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
rosavin results in increased expression of HSPB1 mRNA
CTD
PMID:20706672
NCBI chr12:23,839,390...23,841,051
Ensembl chr12:23,839,399...23,841,049
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
rosavin results in decreased expression of IGF1 mRNA
CTD
PMID:20706672
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Kl
Klotho
decreases expression
ISO
rosavin results in decreased expression of KL mRNA
CTD
PMID:20706672
NCBI chr12:942,974...987,206
Ensembl chr12:943,006...987,551
G
Mc1r
melanocortin 1 receptor
decreases expression
ISO
rosavin results in decreased expression of MC1R mRNA
CTD
PMID:20706672
NCBI chr19:56,215,420...56,219,987
G
Mt-co1
mitochondrially encoded cytochrome c oxidase I
increases expression
ISO
rosavin results in increased expression of COX1 mRNA
CTD
PMID:20706672
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
G
Nos2
nitric oxide synthase 2
decreases expression
ISO
rosavin results in decreased expression of NOS2 mRNA
CTD
PMID:20706672
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
G
Nos3
nitric oxide synthase 3
increases expression
ISO
rosavin results in increased expression of NOS3 mRNA
CTD
PMID:20706672
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Pgr
progesterone receptor
decreases expression
ISO
rosavin results in decreased expression of PGR mRNA
CTD
PMID:20706672
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
G
Plod3
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3
increases expression
ISO
rosavin results in increased expression of PLOD3 mRNA
CTD
PMID:20706672
NCBI chr12:22,716,421...22,726,982
Ensembl chr12:22,716,423...22,726,982
G
Pomc
proopiomelanocortin
decreases expression
ISO
rosavin results in decreased expression of POMC mRNA
CTD
PMID:20706672
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
G
Pparg
peroxisome proliferator-activated receptor gamma
decreases expression
ISO
rosavin results in decreased expression of PPARG mRNA
CTD
PMID:20706672
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
G
Ptger1
prostaglandin E receptor 1
decreases expression
ISO
rosavin results in decreased expression of PTGER1 mRNA
CTD
PMID:20706672
NCBI chr19:24,799,422...24,803,373
Ensembl chr19:24,800,072...24,803,373
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
rosavin results in decreased expression of RAD23A mRNA
CTD
PMID:20706672
NCBI chr19:25,949,488...25,956,677
Ensembl chr19:25,949,490...25,955,391
G
Rxra
retinoid X receptor alpha
decreases expression
ISO
rosavin results in decreased expression of RXRA mRNA
CTD
PMID:20706672
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
G
Sod3
superoxide dismutase 3
decreases expression
ISO
rosavin results in decreased expression of SOD3 mRNA
CTD
PMID:20706672
NCBI chr14:60,958,583...60,971,143
Ensembl chr14:60,958,592...60,964,324
G
Srd5a2
steroid 5 alpha-reductase 2
decreases expression
ISO
rosavin results in decreased expression of SRD5A2 mRNA
CTD
PMID:20706672
NCBI chr 6:25,279,635...25,315,501
Ensembl chr 6:25,279,626...25,315,511
G
Tert
telomerase reverse transcriptase
decreases expression
ISO
rosavin results in decreased expression of TERT mRNA
CTD
PMID:20706672
NCBI chr 1:32,250,876...32,275,330
Ensembl chr 1:32,251,714...32,272,476
G
Tpt1
tumor protein, translationally-controlled 1
increases expression
ISO
rosavin results in increased expression of TPT1 mRNA
CTD
PMID:20706672
NCBI chr15:57,891,680...57,894,504
Ensembl chr15:57,891,680...57,894,504
G
Txn1
thioredoxin 1
increases expression
ISO
rosavin results in increased expression of TXN mRNA
CTD
PMID:20706672
NCBI chr 5:75,049,735...75,057,731
Ensembl chr 5:75,049,747...75,057,752
G
Tyrp1
tyrosinase-related protein 1
decreases expression
ISO
rosavin results in decreased expression of TYRP1 mRNA
CTD
PMID:20706672
NCBI chr 5:98,387,291...98,406,083
Ensembl chr 5:98,387,291...98,406,083
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19883
chemical entity
19883
atom
19881
nonmetal atom
19760
oxygen atom
19425
oxygen molecular entity
19425
organooxygen compound
18886
carbohydrates and carbohydrate derivatives
12267
carbohydrate derivative
11894
O-acyl carbohydrate
32
(2E)-3-phenyl-2-propen-1-yl-6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
0
(2E)-3-phenyl-2-propen-1-yl-6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
0
(2R,3R,4R,5S)-6-\{[3-(4-chlorophenyl)-4-hydroxybutanoyl]oxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid
0
(2R,3R,4S,5S)-3,4,5-trihydroxy-6-(pyridine-4-carbonyl)oxane-2-carboxylic acid
0
(2R,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2R,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
0
(2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(3E)-1-hydroxy-4-[(1R)-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-buten-2-yl beta-D-glucopyranoside
0
(3R)-3,7-dimethyl-1,6-octadien-3-yl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
0
(3Z)-4-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-buten-2-yl beta-D-glucopyranoside
0
1,2-di-O-sinapoyl-beta-D-glucose
0
1-(2-oxindole-3-acetyl)-beta-D-glucose
0
1-(3,4-dihydroxybenzoyl)-beta-D-glucopyranose +
0
1-O-(4-coumaroyl)-beta-D-glucose
0
1-O-(4-hydroxybenzoyl)-beta-D-glucopyranose
0
1-O-acetylmaltose +
0
1-O-alpha-D-Glucopyranosyl-1,2-nonadecandiol
0
1-O-trans-cinnamoyl-beta-D-glucopyranose
0
1-O-vanilloyl-beta-D-glucose
0
2-O-[6-O-octanoyl-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glyceric acid
0
2-O-acetyl-alpha-L-rhamnose
0
2-[4-(1,4-dihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol
0
2-acetamido-2-deoxy-3-O-(beta-D-Galp6S)-D-galactitol
0
2-galloyl-D-glucose
0
2-trans-abscisic acid D-glucosyl ester +
0
20-hydroxy-20-oxoleukotriene B4-20-(beta-D-glucuronide)
0
3-O-(cis-4-coumaroyl)-beta-D-glucopyranose
0
3-O-(trans-4-coumaroyl)-beta-D-glucopyranose
0
3-b-galactopyranosyl glucose
0
3-indole carboxylic acid glucuronide
0
4''-O-Carbamoyl ansamitocinoside P-3
0
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-glucuronide
0
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-glucuronide
0
4-Hydroxy-5-(phenyl)-valeric acid-O-glucuronide
0
5-O-(trans-feruloyl)-L-arabinofuranose
0
6'-O-acetylpaeoniflorin
0
6-O-(trans-4-coumaroyl)-alpha-D-glucopyranose
0
6-O-(trans-4-coumaroyl)-beta-D-glucopyranose
0
6-O-(trans-feruloyl)-D-galactopyranose
0
6-O-acyl-D-glucose +
0
6-O-sinapoylhexose
0
6-hydroxy-2,6-dimethyl-2,7-octadien-1-yl D-glucopyranoside
0
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
0
D-glucosyl 6-hydroxyindole-3-carboxylate
0
D-glucosyl indole-3-carboxylate
0
D-glucosyl salicylate +
0
Eriojaposide B
0
Gusanlungionoside A
0
Gusanlungionoside B
0
Gusanlungionoside C
0
Gusanlungionoside D
0
Heptopyranosides
0
Hexyl glucoside
0
Isoglobotriaose
0
LSM-36697
0
Lauroside B
0
Lavaudioside B
0
Methylpendolmycin-14-O-alpha-glucoside
0
N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,3,5,6-tetrahydroxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,4,5,6-Tetrahydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-3-[(2R,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5-trihydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-3-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5,6-tetrahydroxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-4-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1,3,5,6-tetrahydroxyhexan-2-yl]acetamide
0
O-feruloylgalactaric acid +
0
O-sinapoylglucaric acid +
0
OM-174
0
Rosarin
0
Rosavin
32
Trehalose-6,6'-dibehenate
0
Tuliposide A
0
Tuliposide B
0
Xylopimarane
0
[(2R,3R,4R,5S)-5-Acetamido-2,6-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexyl] hydrogen sulfate
0
[(2R,3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-Acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate
0
[3,4,5-trihydroxy-6-[4-(2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)butan-2-yloxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
0
\{2-[5-(hexopyranosyloxy)pent-2-en-1-yl]-3-oxocyclopentyl\}acetic acid
0
acetyl xylan
0
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH
0
alpha-L-Fucp-(1->3)-D-mannitol
0
alpha-benzoyloxypaeoniflorin
0
anthemis glycoside A
0
anthemis glycoside B
0
ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester +
0
beta-benzoyloxypaeoniflorin
0
chenodeoxycholic acid 24-O-(beta-D-glucuronide)
0
cholic acid 24-O-(beta-D-glucuronide)
0
daidzein 7-(6-O-acetyl-beta-D-glucoside)
0
deoxycholic acid 24-O-(beta-D-glucuronide)
0
ethyl 3-O-beta-D-glucopyranosyl-butanoate
0
galabiose
0
glycitein 7-(6-O-acetyl-beta-D-glucoside)
0
hebitol II
0
hexyl 6-O-pentopyranosylhexopyranoside
0
hyocholic acid 24-O-(beta-D-glucuronide)
0
hyodeoxycholic acid 24-O-(beta-D-glucuronide)
0
isomaltitol
0
lithocholic acid 24-O-(beta-D-glucuronide)
0
litseaefoloside C
0
locoracemoside B
0
locoracemoside C
0
methyl 4,6-di-O-acetyl-beta-D-galactoside
0
methyl 4-[(2',3',4',6'-tetra-O-acetyl)-beta-D-glucopyranosyl]coumarate
0
niruriside
0
octanoyl-beta-D-glucuronide
0
palatinitol
0
penta-O-acetyl-alpha-D-galactose
0
phlomuroside
0
salicyluric beta-D-glucuronide
0
trehalose mycolate +
0
vGSL-like (t16:0/h22:0)
0
vandateroside III, (-)-
0
Path 2
CHEBI ontology
19883
subatomic particle
19881
composite particle
19881
hadron
19881
baryon
19881
nucleon
19881
atomic nucleus
19881
atom
19881
main group element atom
19771
p-block element atom
19771
carbon group element atom
19679
carbon atom
19668
organic molecular entity
19668
heteroorganic entity
19257
organochalcogen compound
18964
organooxygen compound
18886
carbohydrates and carbohydrate derivatives
12267
carbohydrate
12267
carbohydrate derivative
11894
O-acyl carbohydrate
32
(2E)-3-phenyl-2-propen-1-yl-6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
0
(2E)-3-phenyl-2-propen-1-yl-6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
0
(2R,3R,4R,5S)-6-\{[3-(4-chlorophenyl)-4-hydroxybutanoyl]oxy\}-3,4,5-trihydroxyoxane-2-carboxylic acid
0
(2R,3R,4S,5S)-3,4,5-trihydroxy-6-(pyridine-4-carbonyl)oxane-2-carboxylic acid
0
(2R,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2R,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,6-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
0
(2R,3S,4S,5R,6R)-4,6-Dihydroxy-3-[(2R,3R,4R,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-(sulfoamino)-4-sulfooxyoxan-2-yl]oxy-5-sulfooxyoxane-2-carboxylic acid
0
(2S,3S,4R,5R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(2S,3S,4R,5R,6R)-3-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-(sulfoamino)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid
0
(3E)-1-hydroxy-4-[(1R)-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-buten-2-yl beta-D-glucopyranoside
0
(3R)-3,7-dimethyl-1,6-octadien-3-yl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
0
(3Z)-4-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-buten-2-yl beta-D-glucopyranoside
0
1,2-di-O-sinapoyl-beta-D-glucose
0
1-(2-oxindole-3-acetyl)-beta-D-glucose
0
1-(3,4-dihydroxybenzoyl)-beta-D-glucopyranose +
0
1-O-(4-coumaroyl)-beta-D-glucose
0
1-O-(4-hydroxybenzoyl)-beta-D-glucopyranose
0
1-O-acetylmaltose +
0
1-O-alpha-D-Glucopyranosyl-1,2-nonadecandiol
0
1-O-trans-cinnamoyl-beta-D-glucopyranose
0
1-O-vanilloyl-beta-D-glucose
0
2-O-[6-O-octanoyl-alpha-D-glucosyl-(1->6)-alpha-D-glucosyl]-D-glyceric acid
0
2-O-acetyl-alpha-L-rhamnose
0
2-[4-(1,4-dihydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-yloxy]-6-(hydroxymethyl)oxane-3,4,5-triol
0
2-acetamido-2-deoxy-3-O-(beta-D-Galp6S)-D-galactitol
0
2-galloyl-D-glucose
0
2-trans-abscisic acid D-glucosyl ester +
0
20-hydroxy-20-oxoleukotriene B4-20-(beta-D-glucuronide)
0
3-O-(cis-4-coumaroyl)-beta-D-glucopyranose
0
3-O-(trans-4-coumaroyl)-beta-D-glucopyranose
0
3-b-galactopyranosyl glucose
0
3-indole carboxylic acid glucuronide
0
4''-O-Carbamoyl ansamitocinoside P-3
0
4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid-O-glucuronide
0
4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid-O-glucuronide
0
4-Hydroxy-5-(phenyl)-valeric acid-O-glucuronide
0
5-O-(trans-feruloyl)-L-arabinofuranose
0
6'-O-acetylpaeoniflorin
0
6-O-(trans-4-coumaroyl)-alpha-D-glucopyranose
0
6-O-(trans-4-coumaroyl)-beta-D-glucopyranose
0
6-O-(trans-feruloyl)-D-galactopyranose
0
6-O-acyl-D-glucose +
0
6-O-sinapoylhexose
0
6-hydroxy-2,6-dimethyl-2,7-octadien-1-yl D-glucopyranoside
0
Blumenol C O-[rhamnosyl-(1->6)-glucoside]
0
D-glucosyl 6-hydroxyindole-3-carboxylate
0
D-glucosyl indole-3-carboxylate
0
D-glucosyl salicylate +
0
Eriojaposide B
0
Gusanlungionoside A
0
Gusanlungionoside B
0
Gusanlungionoside C
0
Gusanlungionoside D
0
Heptopyranosides
0
Hexyl glucoside
0
Isoglobotriaose
0
LSM-36697
0
Lauroside B
0
Lavaudioside B
0
Methylpendolmycin-14-O-alpha-glucoside
0
N-[(2S,3R,4R,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,3,5,6-tetrahydroxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,4,5-Tetrahydroxy-6-[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,3,5,6-Tetrahydroxy-4-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-1,4,5,6-Tetrahydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-3-[(2R,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5-trihydroxy-6-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-3-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5,6-tetrahydroxyhexan-2-yl]acetamide
0
N-[(2S,3R,4S,5R)-4-[(2S,3S,4S,5R,6R)-3,5-Dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-1,3,5,6-tetrahydroxyhexan-2-yl]acetamide
0
O-feruloylgalactaric acid +
0
O-sinapoylglucaric acid +
0
OM-174
0
Rosarin
0
Rosavin
32
Trehalose-6,6'-dibehenate
0
Tuliposide A
0
Tuliposide B
0
Xylopimarane
0
[(2R,3R,4R,5S)-5-Acetamido-2,6-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexyl] hydrogen sulfate
0
[(2R,3R,4S,5S,6R)-2-[(2S,3R,4S,5R)-2-Acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] hydrogen sulfate
0
[3,4,5-trihydroxy-6-[4-(2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)butan-2-yloxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate
0
\{2-[5-(hexopyranosyloxy)pent-2-en-1-yl]-3-oxocyclopentyl\}acetic acid
0
acetyl xylan
0
alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-2-acetamido-2-deoxy-D-Gal-OH
0
alpha-L-Fucp-(1->3)-D-mannitol
0
alpha-benzoyloxypaeoniflorin
0
anthemis glycoside A
0
anthemis glycoside B
0
ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester +
0
beta-benzoyloxypaeoniflorin
0
chenodeoxycholic acid 24-O-(beta-D-glucuronide)
0
cholic acid 24-O-(beta-D-glucuronide)
0
daidzein 7-(6-O-acetyl-beta-D-glucoside)
0
deoxycholic acid 24-O-(beta-D-glucuronide)
0
ethyl 3-O-beta-D-glucopyranosyl-butanoate
0
galabiose
0
glycitein 7-(6-O-acetyl-beta-D-glucoside)
0
hebitol II
0
hexyl 6-O-pentopyranosylhexopyranoside
0
hyocholic acid 24-O-(beta-D-glucuronide)
0
hyodeoxycholic acid 24-O-(beta-D-glucuronide)
0
isomaltitol
0
lithocholic acid 24-O-(beta-D-glucuronide)
0
litseaefoloside C
0
locoracemoside B
0
locoracemoside C
0
methyl 4,6-di-O-acetyl-beta-D-galactoside
0
methyl 4-[(2',3',4',6'-tetra-O-acetyl)-beta-D-glucopyranosyl]coumarate
0
niruriside
0
octanoyl-beta-D-glucuronide
0
palatinitol
0
penta-O-acetyl-alpha-D-galactose
0
phlomuroside
0
salicyluric beta-D-glucuronide
0
trehalose mycolate +
0
vGSL-like (t16:0/h22:0)
0
vandateroside III, (-)-
0